Yuanlei Fu, Ying Kong, Xiangping Li, Dongfang Cheng, Yuqian Hou, Yan Li, . . . Rong Rong. (2023). Novel Pt(IV) prodrug self-assembled nanoparticles with enhanced blood circulation stability and improved antitumor capacity of oxaliplatin for cancer therapy. Taylor & Francis Group.
Chicago Style (17th ed.) CitationYuanlei Fu, et al. Novel Pt(IV) Prodrug Self-assembled Nanoparticles with Enhanced Blood Circulation Stability and Improved Antitumor Capacity of Oxaliplatin for Cancer Therapy. Taylor & Francis Group, 2023.
MLA (9th ed.) CitationYuanlei Fu, et al. Novel Pt(IV) Prodrug Self-assembled Nanoparticles with Enhanced Blood Circulation Stability and Improved Antitumor Capacity of Oxaliplatin for Cancer Therapy. Taylor & Francis Group, 2023.
Warning: These citations may not always be 100% accurate.